<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
	<head>
		<meta charset="utf-8" />
		<title>BCSC1819_S06_C21_p000-000_1P_v2</title>
		<link href="BCSC1819_S06_C21_p000-000_1P_v2-web-resources/css/idGeneratedStyles.css" rel="stylesheet" type="text/css" />
	</head>
	<body id="BCSC1819_S06_C21_p000-000_1P_v2" lang="en-US">
		<div id="_idContainer000" class="Basic-Text-Frame">
			<p class="chapter-number"><span class="cn-chap">Chapter</span><span class="cn-chap"> </span>21</p>
			<p class="chapter-title ParaOverride-1">Disorders of the Anterior Segment</p>
			<p class="body-text--no-indent-">Disorders of the anterior segment include a wide spectrum of conditions involving the cornea, iris, anterior chamber &#173;angle, and lens. Pediatric glaucoma and lens disorders are discussed in Chapters&#160;22 and 23, respectively. Anatomy of the anterior segment and its development are discussed in BCSC Section&#160;2, <span class="italic">Fundamentals and Princi&#173;ples of Ophthalmology.</span> See also Section&#160;8, <span class="italic">External Disease and Cornea,</span> for detailed discussion of some of the disorders covered in this chapter.</p>
			<p class="h1 ParaOverride-2">Abnormalities of Corneal Size or Shape</p>
			<div id="Chapt21_Top1">
			<p class="h2-h1">Megalocornea</p>
			<p class="body-text--no-indent-"><span class="italic">Primary megalocornea</span> is characterized by bilateral congenitally enlarged corneas, with an increased horizontal corneal dia&#173;meter and a deep anterior chamber (<span class="xref-figure">Fig 21-1</span>); it is often associated with iris transillumination. On biometry, the ratio of anterior chamber depth to total axial length is typically 0.19 or greater, a feature that is useful for distinguishing this anomaly from buphthalmos. Late changes include corneal mosaic degeneration (shagreen), arcus juvenilis, presenile cataracts, and glaucoma. The phenotype is often caused by X-&#173;linked recessive mutation in <span class="italic">CHRDL1</span>. <span class="italic">Secondary megalocornea</span> is typically a result of increased intraocular pressure.</p>
			<p class="reference--journal--single ParaOverride-3">Davidson AE, Cheong SS, Hysi PG, et&#160;al. Association of <span class="italic">CHRDL1</span> mutations and variants with X-&#173;linked megalocornea, Neuh<span class="accent">ä</span>user syndrome and central corneal thickness. <span class="italic">PLoS One.</span> 2014;<br />9(8):e104163.</p>
			<p class="h2 ParaOverride-4">Microcornea</p>
			<p class="body-text--no-indent-"><span class="italic">Microcornea</span> is characterized by a horizontal corneal dia&#173;meter of 9&#160;mm or less at birth and less than 10&#160;mm &#173;after 2&#160;years of age (<span class="xref-figure">Fig 21-2</span>). It is often a component of ocular malformations such as microphthalmia and per&#173;sis&#173;tent fetal vasculature and of syndromes such as oculodentodigital, Nance-&#173;Horan, and Lenz syndromes.</p>
			<p class="h2 ParaOverride-4">Keratoglobus</p>
			<p class="body-text--no-indent-"><span class="italic">Keratoglobus</span> is characterized by a steep corneal curvature, peripheral corneal thinning, and a very deep anterior chamber. The phenotype can be due to brittle cornea syndrome, which is the result of biallelic mutations in <span class="italic">ZNF469</span> or <span class="italic">PRDM5.</span> Spontaneous breaks in Descemet membrane may produce acute corneal edema. &#173;Because the cornea can be ruptured by minor blunt trauma, wearing protective spectacles full time is appropriate.</p>
			<p class="h2 ParaOverride-4">Keratoconus</p>
			<p class="body-text--no-indent-"><span class="italic">Keratoconus</span> is characterized by central or paracentral corneal bulging and progressive thinning. It may pres&#173;ent and pro&#173;gress during adolescence and is often familial. Keratoconus is more common in Down syndrome, atopic diseases, Leber congenital amaurosis, and chronic eye rubbing. Iron lines (Fleischer rings), stress lines (Vogt striae), and apical scarring are often noted. Tears in Descemet membrane can occur and cause acute corneal edema (hydrops).</p>
			</div>
			<p class="h1">Abnormalities of Peripheral Corneal Transparency</p>
			<div id="Chapt21_Top2">
			<p class="h2-h1">Posterior Embryotoxon</p>
			<p class="body-text--no-indent-"><span class="italic">Posterior embryotoxon (prominent Schwalbe line)</span> represents a thickening and anterior displacement of the Schwalbe line, causing the anomaly to be seen as an irregular white line just concentric with and anterior to the limbus (<span class="xref-figure">Fig 21-3</span>). It is a common isolated finding (occurring in 15% of healthy patients) but is often seen in Axenfeld-&#173;Rieger syndrome, arteriohepatic dysplasia (Alagille syndrome), and velocardiofacial syndrome (22q11 deletion syndrome).</p>
			<p class="h2 ParaOverride-5">Cornea Plana</p>
			<p class="body-text--no-indent-"><span class="italic">Cornea plana</span> is a pathognomonic phenotype of flat cornea, indistinct limbus, shallow anterior chamber, hyperopia, and associated accommodative esotropia (<span class="xref-figure">Fig 21-4</span>); it is specific for biallelic <span class="italic">KERA</span> mutations. Refractive correction and monitoring for glaucoma, which may develop &#173;later in life, are the mainstays of treatment.</p>
			<p class="reference--journal--single">Khan AO, Aldahmesh M, Meyer&#160;B. Recessive cornea plana in the Kingdom of Saudi Arabia. <span class="italic">Ophthalmology.</span> 2006;113(10):1773–1778.</p>
			<p class="h2 ParaOverride-6">Epibulbar Dermoid</p>
			<p class="body-text--no-indent-">An <span class="italic">epibulbar (limbal) dermoid</span> is a choristoma composed of fibrofatty tissue covered by keratinized epithelium; it may contain hair follicles, sebaceous glands, or sweat glands. The dermoid often straddles the limbus (typically inferotemporally) or, less frequently, resides more centrally in the cornea. It is less than 10&#160;mm in dia&#173;meter, with minimal postnatal growth. The dermoid may extend into the corneal stroma and adjacent sclera but seldom encompasses the full thickness (<span class="xref-figure">Fig 21-5</span>). Often, a lipoid infiltration of the corneal stroma is noted at the leading edge. Sometimes the lesion is continuous with epibulbar dermolipomas that involve the lateral quadrant of the eye.</p>
			<p class="body-text">Epibulbar dermoids may be seen in Goldenhar syndrome (see also Chapter&#160;18). Patients with Goldenhar syndrome may have one or more of a variety of anomalies, including ear deformities or periauricular tags, maxillary or mandibular hypoplasia, vertebral deformities, eyelid colobomas, or Duane retraction syndrome.</p>
			<p class="body-text">Epibulbar dermoids can produce astigmatism with secondary anisometropic amblyopia. Large epibulbar dermoids can block the visual axis. Surgical excision may be indicated if they cause ocular irritation or amblyopia, but the procedure may result in scarring and astigmatism, which can also lead to amblyopia. Although excision &#173;will not eliminate the preexisting astigmatism, surgery may be useful for treating very elevated lesions. Tumor removal involves excising the episcleral portion flush with the plane of surrounding tissue. In general, the surgeon need not remove under&#173;lying clear corneal tissue, mobilize surrounding tissue, or apply a patch graft over the resulting surface defect; however, &#173;because some lesions extend into the anterior chamber, tissue should be available in the event that a patch graft is required. The cornea and conjunctiva heal within a few days to several weeks, generally with some scarring and imperfect corneal transparency; nevertheless, the appearance can be improved considerably.</p>
			<p class="h2">Dermolipoma</p>
			<p class="body-text--no-indent-">A <span class="italic">dermolipoma</span> is an epibulbar choristoma composed of adipose and dense connective tissue. Often, dermal tissue, including hairs, has replaced a portion of the overlying conjunctiva. Dermolipomas can be extensive, involving orbital tissue, the lacrimal gland, extraocular muscle, or a combination of &#173;these. Like limbal dermoids, dermolipomas can be associated with Goldenhar syndrome (see Chapter&#160;18).</p>
			<p class="body-text">Dermolipomas rarely require excision. If surgery is undertaken, the surgeon should attempt to remove only the portion of the lesion that is vis&#173;i&#173;ble within the palpebral fissure, disturbing the conjunctiva and the Tenon layer as &#173;little as pos&#173;si&#173;ble to minimize scarring and the risks of strabismus and dry eye. Cicatrization may occur even with a conservative operative approach.</p>
			</div>
			<p class="h1 ParaOverride-7">Abnormalities of Central and Diffuse Corneal Transparency</p>
			<div id="Chapt21_Top3">
			<p class="body-text--no-indent-">The mnemonic <span class="italic">STUMPED</span> refers to <span class="italic">s</span>clerocornea, <span class="italic">t</span>ears in Descemet membrane (usually owing to forceps trauma or congenital glaucoma), <span class="italic">u</span>lcers (infection; see Chapter&#160;28), <span class="italic">m</span>etabolic disorders (eg, mucopolysaccharidosis), <span class="italic">P</span>eters anomaly, <span class="italic">e</span>dema (eg, congenital hereditary endothelial dystrophy [CHED], posterior polymorphous corneal dystrophy [PPCD], congenital hereditary stromal dystrophy [CHSD], glaucoma), and <span class="italic">d</span>ermoid (<span class="xref-table">&#173;Table&#160;21-1</span>). Although this mnemonic has been used when the differential diagnosis of corneal opacity in young patients is considered, an alternative and more useful classification of corneal opacities is based on &#173;whether they are primary or secondary (<span class="xref-table">&#173;Table&#160;21-2</span>).</p>
			<p class="h2">Primary &#173;Causes</p>
			<p class="h3-h2">Congenital hereditary endothelial dystrophy</p>
			<p class="body-text--no-indent-">In CHED, the cornea is diffusely and uniformly edematous (thick), often with a mosaic haze (<span class="xref-figure">Fig 21-6</span>). The phenotype is specific for biallelic <span class="italic">SLC4A11</span> mutations. On mea&#173;sure&#173;ment, intraocular pressure is sometimes falsely elevated, which can lead to the misdiagnosis of glaucoma. Deafness pres&#173;ents &#173;later in some cases (Harboyan syndrome).</p>
			<p class="h3 ParaOverride-8">Congenital hereditary stromal dystrophy</p>
			<p class="body-text--no-indent-">An autosomal dominant condition, CHSD is extremely rare. It is characterized by a smooth, normal epithelium with flaky or feathery clouding of the stroma, which is of normal thickness.</p>
			<p class="reference--journal--single ParaOverride-3">Weiss JS, M<span class="accent">ø</span>ller HU, Aldave AJ, et&#160;al. IC3D classification of corneal dystrophies—&#173;edition 2. <span class="italic">Cornea.</span> 2015;34(2):117–159. [Erratum appears in <span class="italic">Cornea.</span> 2015;34(10):e32.]</p>
			<p class="h2 ParaOverride-4">Secondary &#173;Causes</p>
			<p class="h3-h2">Posterior corneal depression</p>
			<p class="body-text--no-indent-"><span class="italic">Posterior corneal depression (central posterior keratoconus; von Hippel internal ulcer)</span> is a discrete posterior corneal indentation with a normal anterior curvature; it can be considered a variant of Peters anomaly (see the following section). Pigment deposits sometimes are seen on the border of the defect. An abnormal red reflex is noted during examination with a retinoscope or direct ophthalmoscope. If refractive correction is not successful, Descemet stripping endothelial keratoplasty (DSEK) can be considered.</p>
			<p class="h3 ParaOverride-8">Peters anomaly</p>
			<p class="body-text--no-indent-"><span class="italic">Peters anomaly (kerato-&#173;irido-&#173;lenticular dysgenesis)</span> is characterized by a posterior corneal defect with an overlying stromal opacity, often accompanied by adherent iris strands (Peters anomaly type 1; <span class="xref-figure">Fig 21-7A</span>). A more severe phenotype includes adherence of the lens to the cornea at the site of the central defect (Peters anomaly type 2; <span class="xref-figure">Fig 21-7B</span>). The corneal opacity ranges from a dense to mild central leukoma (<span class="xref-figure">Fig 21-7C</span>). In severe cases, the central leukoma may be vascularized and protrude above the level of the cornea. In rare cases, a membrane may form posterior to the posterior corneal defect, causing the appearance of a central cyst in an opacified cornea (<span class="xref-figure">Fig 21-7D</span>). The stromal opacity may decrease with time in some cases. Lysis of adherent iris strands has been reported to improve corneal clarity in some cases.</p>
			<p class="body-text">Peters anomaly can arise from a variety of gene mutations (eg, heterozygous <span class="italic">PAX6</span> mutation, biallelic <span class="italic">CYP1B1</span> mutations) or from in utero insult (eg, congenital rubella). Unilateral cases are usually isolated. Bilateral cases warrant a complete ge&#173;ne&#173;tic evaluation. One Peters anomaly syndrome is <span class="italic">Peters-&#173;plus syndrome,</span> which is caused by biallelic <span class="italic">B3GLCT</span> mutations. Peters-&#173;plus syndrome is associated with short stature, a distinct craniofacial appearance, shortened fin&#173;gers and toes, and intellectual disability. In this syndrome, the stromal opacity may diminish with time.</p>
			<p class="reference--journal--first ParaOverride-9">Bhandari R, Ferri S, Whittaker B, Liu M, Lazzaro DR.&#160;Peters anomaly: review of the lit&#173;er&#173;a&#173;ture. <span class="italic">Cornea.</span> 2011;30(8):939–944.</p>
			<p class="reference--journal--mid">Khan AO, Al-&#173;Katan H, Al-&#173;Gehedan S, Al-&#173;Rashed&#160;W. Bilateral congenital stromal cyst of the cornea. <span class="italic">J AAPOS.</span> 2007;11(4):400–401.</p>
			<p class="reference--journal--last">Nischal KK. Ge&#173;ne&#173;tics of congenital corneal opacification—&#173;impact on diagnosis and treatment. <span class="italic">Cornea.</span> 2015;34(Suppl 10):S24–&#173;S34.</p>
			<p class="h3-h2">Sclerocornea</p>
			<p class="body-text--no-indent-"><span class="italic">Sclerocornea (total corneal opacification)</span> is a descriptive term for a congenitally opaque cornea resembling sclera (<span class="xref-figure">Fig 21-8</span>). As it is a vague term that does not suggest causation, its use should be avoided.</p>
			<p class="h3 ParaOverride-8">Congenital or infantile glaucoma</p>
			<p class="body-text--no-indent-">Glaucoma in young &#173;children can cause the cornea to become edematous, cloudy, and enlarged. Breaks in Descemet membrane from glaucomatous enlargement are termed <span class="italic">Haab striae</span> (<span class="xref-figure">Figs 21-9</span>, <span class="xref-figure">21-10</span>). See Chapter&#160;22 for further discussion.</p>
			<p class="h3">Traumatic breaks in Descemet membrane</p>
			<p class="body-text--no-indent-">Traumatic breaks in Descemet membrane can be caused by forceps trauma during delivery. Other signs of trauma are frequently apparent on the child’s head. Traumatic breaks are usually vertical and linear, unlike the curvilinear and often horizontal Haab striae of congenital glaucoma. Acute rupture leads to stromal and sometimes epithelial edema. Acute stromal and epithelial edema regresses, but the edges of the broken Descemet membrane persist and can be seen as ridges protruding slightly from the posterior corneal surface. Amblyopia may result from prolonged corneal opacity or, more commonly, from induced anisometropic astigmatism. In patients with brittle cornea syndrome, a disorder of corneal fragility caused by biallelic mutations in <span class="italic">ZNF469</span> or <span class="italic">PRDM5,</span> minor trauma can cause traumatic breaks in Descemet membrane (<span class="xref-figure">Fig 21-11</span>).</p>
			<p class="reference--journal--single">Khan AO. Conditions that can be mistaken as early childhood glaucoma. <span class="italic">Ophthalmic Genet.</span> 2011;32(3):129–137.</p>
			<p class="h3">Corneal ulcers</p>
			<p class="body-text--no-indent-">Congenital corneal ulcers are rare and may be caused by herpes simplex keratitis or other infection (see Chapter&#160;28).</p>
			<p class="h2">Treatment of Corneal Opacities</p>
			<p class="body-text--no-indent-">If bilateral dense opacities are pres&#173;ent, early keratoplasty can be considered for 1 eye so that deprivation amblyopia can be minimized. Coexistent anterior segment disease must be considered before keratoplasty is undertaken. If the opacity is unilateral, the decision is more difficult. Keratoplasty should be undertaken only if the &#173;family and the ophthalmologists involved in the child’s care are prepared for the significant commitment of time and effort needed to deal with corneal graft rejection, which occurs often in &#173;children, as well as with amblyopia. The team should include ophthalmologists skilled in pediatric corneal surgery, pediatric glaucoma, and amblyopia. Contact lens expertise is impor&#173;tant for the care of infants with small eyes and large refractive errors. Repeated examinations &#173;under anesthesia are often required.</p>
			<p class="body-text">In addition to traditional penetrating keratoplasty, treatment options include optical iridectomy, deep anterior lamellar keratoplasty (DALK; used for stromal disease with healthy endothelium), DSEK (used to replace diseased endothelium or Descemet membrane), and keratoprostheses.</p>
			<p class="reference--journal--first">Ashar JN, Ramappa M, Vaddavalli PK. Paired-&#173;eye comparison of Descemet’s stripping endothelial keratoplasty and penetrating keratoplasty in &#173;children with congenital hereditary endothelial dystrophy. <span class="italic">Br J Ophthalmol.</span> 2013;97(10):1247–1249.</p>
			<p class="reference--non-journal--mid">Harding SA, Nischal KK, Upponi-&#173;Patil A, Fowler DJ. Indications and outcomes of deep anterior lamellar keratoplasty in &#173;children. <span class="italic">Ophthalmology.</span> 2010;117(11):2191–2195.</p>
			</div>
			<p class="h1 ParaOverride-10">Congenital and Developmental Anomalies of the Globe</p>
			<div id="Chapt21_Top4">
			<p class="h2-h1">Microphthalmia, Anophthalmia, and Coloboma</p>
			<p class="body-text--no-indent-">Microphthalmia, anophthalmia, and coloboma (MAC) is a spectrum that may be isolated or syndromic. It has been associated with mutations in numerous genes, including <span class="italic">CHX10, MAF, PAX6, PAX2, RAX, SHH, SIX3,</span> and <span class="italic">SOX2.</span></p>
			<p class="h3">Microphthalmia</p>
			<p class="body-text--no-indent-"><span class="italic">Microphthalmia</span> is a small, disor&#173;ga&#173;nized globe that can be associated with cystic outpouching of the posteroinferior sclera.</p>
			<p class="h3">Anophthalmia</p>
			<p class="body-text--no-indent-"><span class="italic">Anophthalmia</span> is absence of any ocular globe tissue (see Chapter&#160;18). It is very rare; usually, when anophthalmia is clinically suspected, the child actually has severe microphthalmia.</p>
			<p class="h3">Coloboma</p>
			<p class="body-text--no-indent-"><span class="italic">Coloboma</span> is the most common and least severe manifestation of the MAC spectrum. It is typically an inferonasal gap in the iris or ret&#173;ina. Coloboma results from failure of the embryonic fissure to close in the fifth week of gestation.</p>
			<p class="h2">Nanophthalmos</p>
			<p class="body-text--no-indent-"><span class="italic">Nanophthalmos</span> is a small eye, typically with an axial length of 18&#160;mm or less and with associated high hyperopia. The cornea is abnormally steep in the recessive form, distinguishing it from ordinary hyperopia. The lens-&#173;to-&#173;eye ratio is high, with a shallow anterior chamber and risk for angle-&#173;closure glaucoma. Another distinguishing feature is a characteristic papillomacular fold. The phenotype can result from biallelic mutations in <span class="italic">PRSS56</span> or <span class="italic">MFRP</span> or from heterozygous mutations in <span class="italic">TMEM98.</span> When the anterior segment is of grossly normal depth, the phenotype is termed <span class="italic">posterior microphthalmos</span>.</p>
			<p class="reference--journal--single ParaOverride-11">Nowilaty SR, Khan AO, Aldahmesh MA, Tabbara KF, Al-&#173;Amri A, Alkuraya FS. Biometric and molecular characterization of clinically diagnosed posterior microphthalmos. <span class="italic">Am J Ophthalmol.</span> 2013;155(2):361–372.e7.</p>
			</div>
			<p class="h1">Congenital and Developmental Anomalies of the Iris or Pupil</p>
			<div id="Chapt21_Top5">
			<p class="h2-h1">Abnormalities of the Iris</p>
			<p class="h3-h2">Per&#173;sis&#173;tent pupillary membrane</p>
			<p class="body-text--no-indent-"><span class="italic">Per&#173;sis&#173;tent pupillary membrane</span> (<span class="xref-figure">Fig 21-12</span>) is the most common developmental abnormality of the iris; it can be seen in approximately 95% of newborns. Remnants are common in older &#173;children and adults. Per&#173;sis&#173;tent pupillary membranes are rarely visually significant. If especially prominent, they can adhere to the anterior lens capsule, causing a small anterior polar cataract. They may be associated with other anterior segment abnormalities.</p>
			<p class="h3">Iris hypoplasia</p>
			<p class="body-text--no-indent-"><span class="italic">Iris hypoplasia</span> refers to an underdeveloped iris stroma. It may be focal (iris coloboma) or diffuse (aniridia). If only the posterior pigment epithelium is underdeveloped, iris transillumination occurs.</p>
			<p class="h4-text"><span class="h4-head">Axenfeld-&#173;Rieger syndrome</span> <span class="italic">Axenfeld-&#173;Rieger syndrome (ARS)</span> is the commonest cause of iris (stromal) hypoplasia. Characteristic findings include posterior embryotoxon with attached iris strands and iris hypoplasia. &#173;These patients have a 50% lifetime risk of glaucoma (<span class="xref-figure">Figs&#160;21-13</span>, <span class="xref-figure">21-14</span>, <span class="xref-figure">21-15</span>). ARS is a spectrum that shows phenotypic and ge&#173;ne&#173;tic heterogeneity. Conditions previously considered distinct—&#173;such as Axenfeld anomaly, Rieger anomaly or syndrome, iridogoniodysgenesis anomaly or syndrome, iris hypoplasia, and familial glaucoma iridogoniodysplasia—&#173;are now recognized as part of the spectrum of ARS.</p>
			<p class="body-text">The features of ARS range from a smooth, cryptless iris surface to a phenotype that mimics aniridia. Examples include mild stromal thinning, marked atrophy with hole formation, corectopia, and ectropion uveae. Posterior embryotoxon, megalocornea (secondary to glaucoma), or microcornea may occur. Associated nonocular abnormalities include abnormal teeth, distinct facies, redundant periumbilical skin, hypospadias, cardiac valve abnormalities, and pituitary abnormalities. Heterozygous mutations in <span class="italic">PITX2</span> or <span class="italic">FOXC1</span>, homeobox genes that regulate other ocular developmental genes, are the most common identifiable cause.</p>
			<p class="h4-text"><span class="h4-head">Iris transillumination</span> <span class="italic">Iris transillumination</span> results from the absence of pigment in the posterior epithelial layers (albinism) or from iris hypoplasia (as part of anterior segment dysgenesis, as in ARS). Iris transillumination has also been reported in Marfan syndrome, Prader-&#173;Willi syndrome, ectopia lentis et pupillae, X-&#173;linked megalocornea, and microcoria. Patchy areas of transillumination can also be seen &#173;after trauma, surgery, or uveitis. Scattered iris transillumination defects may be a normal variant in individuals with very lightly pigmented irides.</p>
			<p class="h4-text"><span class="h4-head">Coloboma of the iris</span> With a typical inferonasal iris coloboma, the pupil is &#173;shaped like a lightbulb, keyhole, or inverted teardrop (<span class="xref-figure">Fig 21-16</span>). Typical colobomas may also involve the lens, ciliary body, choroid, ret&#173;ina, or optic nerve and are part of the MAC spectrum (discussed previously in this chapter). Parents of an affected child may have small, previously undetected chorioret&#173;i&#173;nal or iris defects in an inferonasal location; thus, careful examination of &#173;family members is indicated.</p>
			<p class="body-text">Aty&#173;pi&#173;cal iris colobomas occur in areas other than the inferonasal quadrant and are not usually associated with posterior uveal colobomas. &#173;These colobomas prob&#173;ably result from fibrovascular remnants of the anterior hyaloid system and pupillary membrane.</p>
			<p class="h4-text ParaOverride-9"><span class="h4-head">Aniridia</span> Classic <span class="italic">aniridia</span> is a panocular bilateral disorder. The term is a misnomer, however, &#173;because at least a rudimentary iris is always pres&#173;ent. The degree of iris formation ranges from almost total absence to only mild hypoplasia, overlapping with ARS. The typical pre&#173;sen&#173;ta&#173;tion is an infant with nystagmus who appears to have absent irides or dilated, unresponsive pupils. Examination findings commonly include small anterior polar lens opacities, at times with attached strands of per&#173;sis&#173;tent pupillary membranes (<span class="xref-figure">Fig 21-17</span>). Foveal hypoplasia is usually pres&#173;ent, with visual acuity often less than 20/100. Glaucoma, typically juvenile, and optic nerve hypoplasia are common. Corneal opacification often develops &#173;later in childhood and may lead to progressive deterioration of visual acuity. The corneal abnormality is due to a stem cell deficiency; therefore, keratolimbal allograft stem cell transplantation may be a more effective treatment than corneal transplantation.</p>
			<p class="body-text">Heterozygous <span class="italic">PAX6</span> gene mutations (11p13) cause classic aniridia, particularly nonsense mutations (haploinsufficiency). Missense mutations are more likely associated with variable expressivity and partial phenotypes. Most (approximately two-&#173;thirds) aniridic &#173;children have the familial form. The <span class="italic">PAX6</span> gene is a homeotic eye morphogenesis control gene involved in complex interactions between the optic cup, surface ectoderm, and neural crest during formation of the iris and other ocular structures.</p>
			<p class="body-text">Approximately one-&#173;third of aniridia cases result from new deletions that, if large enough, can also affect the contiguous <span class="italic">WT1</span> gene (a contiguous gene syndrome); such patients are therefore at risk for Wilms tumor (nephroblastoma) before 5&#160;years of age. This phenotype is part of the WAGR syndrome (<span class="italic">W</span>ilms tumor, <span class="italic">a</span>niridia, <span class="italic">g</span>enitourinary malformations, and &#173;mental <span class="italic">r</span>etardation). All &#173;children with sporadic aniridia should undergo chromosomal deletion analy&#173;sis of 11p13 to exclude increased Wilms tumor risk. Familial aniridia does not carry a significant risk, although &#173;there have been rare reports of Wilms tumor associated with familial aniridia.</p>
			<p class="h3 ParaOverride-8">Congenital iris ectropion</p>
			<p class="body-text--no-indent-">Ectropion of the posterior pigment epithelium onto the anterior surface of the iris is sometimes termed <span class="italic">ectropion uveae,</span> but this is a misnomer &#173;because posterior iris epithelium is derived from neural ectoderm and is not considered part of the uvea. Congenital iris ectropion can occur as an acquired tractional abnormality, often associated with rubeosis iridis, or as a congenital nonprogressive abnormality, which can be associated with &#173;later glaucoma. It may occur in patients with neurofibromatosis, facial hemihypertrophy, or Prader-&#173;Willi syndrome. <span class="italic">Congenital iris ectropion syndrome</span> is a constellation of unilateral congenital iris ectropion, a glassy-&#173;smooth cryptless iris surface, a high iris insertion, dysgenesis of the drainage &#173;angle, and glaucoma risk, often with ptosis.</p>
			<p class="h2 ParaOverride-12">Abnormalities in the Size, Shape, or Location of the Pupil</p>
			<p class="h3-h2">Dyscoria</p>
			<p class="body-text--no-indent-"><span class="italic">Dyscoria</span> is an abnormal pupil shape, typically resulting from congenital malformation such as ARS (see Fig 21-14).</p>
			<p class="h3 ParaOverride-8">Congenital miosis</p>
			<p class="body-text--no-indent-"><span class="italic">Congenital miosis (microcoria)</span> may represent an absence or malformation of the dilator pupillae muscle. It can also occur secondary to contracture of fibrous material on the pupil margin owing to remnants of the tunica vasculosa lentis or neural crest cell anomalies. The pupil rarely exceeds 2&#160;mm in dia&#173;meter, is often eccentric, and reacts poorly to my&#173;d&#173;riatic drops. Severe cases require surgical pupilloplasty. <span class="italic">Ectopia lentis et pupillae</span> refers to eccentric microcoria with lens subluxation, often from biallelic <span class="italic">ADAMTSL4</span> mutations (also see the section “Corectopia”).</p>
			<p class="h3">Congenital mydriasis</p>
			<p class="body-text--no-indent-">Many cases of <span class="italic">congenital mydriasis (iridoplegia)</span> fall within the aniridia spectrum, especially if the central iris structures from the collarette to the pupillary sphincter are absent. Congenital cardiovascular defects may be associated with congenital mydriasis in patients with heterozygous <span class="italic">ACTA2</span> mutation, which sometimes &#173;causes an alternate phenotype of prominent iris flocculi rather than iridoplegia. Other &#173;causes include iris sphincter trauma, pharmacologic mydriasis, and acquired neurologic disease that affects parasympathetic innervation.</p>
			<p class="reference--journal--single">Milewicz DM, <span class="accent">Ø</span>stergaard JR, Ala-&#173;Kokko LM, et&#160;al. De novo <span class="italic">ACTA2</span> mutation &#173;causes a novel syndrome of multisystemic smooth muscle dysfunction. <span class="italic">Am J Med Genet&#160;A.</span> 2010;152A(10):<br />2437–2443.</p>
			<p class="h3">Corectopia</p>
			<p class="body-text--no-indent-">Normally, the pupil is located approximately 0.5&#160;mm inferonasally from the center of the iris. Minor deviations of up to 1.0&#160;mm are usually cosmetically insignificant and are not considered abnormal; displacement greater than this is considered <span class="italic">corectopia.</span> Sector iris hypoplasia or other colobomatous lesions can lead to corectopia. Vision can be good.</p>
			<p class="body-text">Isolated noncolobomatous, autosomal dominant corectopia has been reported. Progressive corectopia can be associated with ARS or, in adults, with iridocorneal endothelial (ICE) syndrome.</p>
			<p class="body-text"><span class="italic">Ectopia lentis et pupillae</span> is corectopia associated with lens subluxation. It is often due to biallelic <span class="italic">ADAMTS4</span> mutations. The pupils and lenses are displaced in opposite directions. The pupils may be very small and misshapen; they often dilate poorly (see Chapter&#160;23).</p>
			<p class="h3">Polycoria and pseudopolycoria</p>
			<p class="body-text--no-indent-">True <span class="italic">polycoria</span> (in which each pupil has a sphincter mechanism) is very rare. Most accessory iris openings are <span class="italic">pseudopolycoria.</span> &#173;These iris holes may be congenital or may develop in response to progressive corectopia and iris hypoplasia in ARS (<span class="xref-figure">Fig 21-18</span>) or, in adults, in ICE syndrome. Pseudopolycoria can also result from trauma, surgery, or per&#173;sis&#173;tent pupillary membranes.</p>
			</div>
			<p class="h1">Acquired Corneal Conditions</p>
			<div id="Chapt21_Top6">
			<p class="h2-h1">Keratitis</p>
			<p class="body-text--no-indent-">Keratitis may be epithelial, stromal, peripheral, or, in rare cases, endothelial.</p>
			<p class="h3">Infectious &#173;causes</p>
			<p class="h4-text ParaOverride-13"><span class="h4-head">Congenital syphilis</span> Interstitial keratitis may occur in the first de&#173;cade of life secondary to congenital syphilis (discussed in Chapter&#160;28). The keratitis pres&#173;ents as a rapidly progressive corneal edema followed by abnormal vascularization in the deep stroma adjacent to Descemet membrane. Intense vascularization may give the cornea a salmon-&#173;pink color—&#173;hence the term <span class="italic">salmon patch.</span> Blood flow through &#173;these vessels gradually ceases over several weeks to several months, leaving empty “ghost” vessels in the corneal stroma. Immune-&#173;mediated uveitis, arthritis, and hearing loss may also develop and may recur even &#173;after treatment of syphilis. Immunosuppression may be necessary to diminish sequelae.</p>
			<p class="h4-text"><span class="h4-head">Herpes simplex infection</span> Eye involvement in congenital herpes simplex virus (HSV) infection can include conjunctivitis, keratitis, retinochoroiditis, and cataracts. Congenital HSV infection is discussed in Chapter&#160;28.</p>
			<p class="h4-text"><span class="h4-head">Adenovirus infection</span> Punctate epithelial keratitis is most often seen &#173;after adenoviral infection; it is due to subepithelial immune complex deposition. See BCSC Section&#160;8, <span class="italic">External Disease and Cornea,</span> for further discussion.</p>
			<p class="h3">Noninfectious &#173;causes</p>
			<p class="body-text--no-indent-">Punctate epithelial erosions are most commonly seen in patients with lagophthalmos or dry eye disease. Peripheral (marginal) keratitis is usually associated with blepharokeratoconjunctivitis secondary to meibomian gland disease.</p>
			<p class="h4-text"><span class="h4-head">Thygeson superficial punctate keratitis</span> The etiology of <span class="italic">Thygeson superficial punctate keratitis</span> is unclear, but it is thought to be immune-&#173;mediated. It can occur in &#173;children and pres&#173;ents with tearing, photophobia, and reduced vision. The condition is bilateral but often asymmetric. Characteristic features include slightly elevated gray corneal epithelial lesions with negative staining. It is treated with mild corticosteroids (eg, fluorometholone 0.1%) or topical cyclosporine 0.05%.</p>
			<p class="h4-text"><span class="h4-head">Cogan syndrome</span> This syndrome is a rare vasculitis that pres&#173;ents with ocular, audiovestibular, and systemic features. Interstitial keratitis, uveitis, conjunctivitis, episcleritis, or a combination of &#173;these features may be seen.</p>
			</div>
			<p class="h1">Systemic Diseases Affecting the Cornea or Iris</p>
			<div id="Chapt21_Top7">
			<p class="h2-h1">Metabolic Disorders Affecting the Cornea or Iris</p>
			<p class="body-text--no-indent-">See also Chapter&#160;28, Ocular Manifestations of Systemic Disease, and &#173;Table&#160;28-2.</p>
			<p class="h3">Mucopolysaccharidosis</p>
			<p class="body-text--no-indent-">The mucopolysaccharidoses (MPSs) are a group of lysosomal storage diseases. Ocular manifestations can include corneal haze from incompletely degraded glycosaminoglycan. Corneal haze may be pres&#173;ent in early life in MPS IH (Hurler syndrome), MPS IS (Scheie syndrome), and MPS IV (Morquio syndrome). Treatment options for significant opacities include penetrating keratoplasty and DALK. Enzyme replacement therapy is available for certain forms of &#173;these lysosomal storage diseases. See BCSC Section&#160;8, <span class="italic">External Disease and Cornea,</span> for further discussion.</p>
			<p class="h3 ParaOverride-8">Cystinosis</p>
			<p class="body-text--no-indent-"><span class="italic">Cystinosis</span> is caused by biallelic <span class="italic">CTNS</span> mutations. The infantile form includes failure to thrive, rickets, and progressive renal failure, resulting in Fanconi syndrome.</p>
			<p class="body-text">Iridescent, elongated corneal crystals appear at approximately age 1 year, first in the peripheral cornea and the anterior stroma. Crystals also pres&#173;ent in the uvea and on the surface of the iris. Corneal crystals result in severe photophobia. &#173;There are reports of angle-&#173;closure glaucoma secondary to crystal deposition in the ciliary body.</p>
			<p class="body-text">Oral cysteamine alleviates systemic prob&#173;lems but not the corneal crystal deposition. Topical cysteamine can reduce corneal crystal deposition but requires frequent application, may be difficult to obtain, and has an unpleasant odor.</p>
			<p class="h3 ParaOverride-8">Tyrosinemia type II</p>
			<p class="body-text--no-indent-"><span class="italic">Tyrosinemia type II (Richner-&#173;Hanhart syndrome)</span> results from biallelic <span class="italic">TAT</span> mutations and is associated with photophobia, pseudodendritic ulcers on the cornea, and ulceration on the palms and &#173;soles. Systemic prob&#173;lems include liver and kidney dysfunction. Dietary restriction of phenylalanine and tyrosine is the mainstay of treatment.</p>
			<p class="h3 ParaOverride-8">Wilson disease</p>
			<p class="body-text--no-indent-">In <span class="italic">Wilson disease (hepatolenticular degeneration),</span> &#173;there is excess copper deposition in the liver, kidneys, and basal ganglia of the brain, leading to cirrhosis, renal tubular damage, and a Parkinson-&#173;like disorder of motor function. The phenotype results from biallelic <span class="italic">ATP7B</span> mutations. The characteristic Kayser-&#173;Fleischer ring—&#173;a golden-&#173;brown, ruby-&#173;red, or green pigment ring consisting of copper deposits—is limited to Descemet membrane, can be several millimeters in width, and may resolve with treatment. Laboratory tests for serum copper and ceruloplasmin are better than an eye examination for early diagnosis &#173;because the ring can develop late.</p>
			<p class="h3 ParaOverride-8">Fabry disease</p>
			<p class="body-text--no-indent-"><span class="italic">Fabry disease</span> is an X-&#173;linked lysosomal storage disease with variable systemic manifestations. It is due to <span class="greek-tx">α</span>-&#173;galactosidase deficiency (hemizygous <span class="italic">GLA</span> mutations). Vortex keratopathy (verticillata) can be seen in affected males and in female carriers.</p>
			<p class="h3 ParaOverride-8">Schnyder corneal dystrophy</p>
			<p class="body-text--no-indent-"><span class="italic">Schnyder corneal dystrophy</span> is a predominantly local disorder of corneal lipid metabolism arising from biallelic <span class="italic">UBIAD1</span> mutations. Although crystalline keratopathy is characteristic, stromal haze without crystals is a common pre&#173;sen&#173;ta&#173;tion.</p>
			<p class="h2">Other Systemic Diseases Affecting the Cornea or Iris</p>
			<p class="h3-h2">Familial dysautonomia</p>
			<p class="body-text--no-indent-"><span class="italic">Familial dysautonomia (Riley-&#173;Day syndrome)</span> is a disorder of autonomic dysfunction characterized by relative insensitivity to pain, temperature instability, and absence of the fungiform papillae of the tongue. The phenotype occurs largely in &#173;children of Eastern Eu&#173;ro&#173;pean Jewish (Ashkenazic) descent and results from biallelic <span class="italic">IKBKAP</span> mutations. Failure to respond with a wheal and flare to intradermal injection of 1:1000 histamine solution is characteristic. Exposure keratitis and corneal ulcers with secondary opacification are frequent. Treatment includes artificial tears and tarsorrhaphy.</p>
			<p class="h3 ParaOverride-8">Waardenburg syndrome</p>
			<p class="body-text--no-indent-"><span class="italic">Waardenburg syndrome</span> is a rare neurocristopathy characterized by Hirschsprung disease; deafness; and depigmentation of hair (a white forelock), skin, and iris. Ophthalmic findings include telecanthus and dystopia canthorum (see Chapter&#160;17).</p>
			</div>
			<p class="h1 ParaOverride-14">Tumors of the Anterior Segment</p>
			<div id="Chapt21_Top8">
			<p class="h2-h1">Cornea</p>
			<p class="body-text--no-indent-">Tumors of the cornea are extremely rare in &#173;children, but squamous cell carcinomas have been reported in cases of xeroderma pigmentosum.</p>
			<p class="h2 ParaOverride-15">Iris</p>
			<p class="h3-h2">Nodules</p>
			<p class="h4-text ParaOverride-13"><span class="h4-head">Lisch nodules</span> <span class="italic">Lisch nodules</span> occur in patients with neurofibromatosis and are discussed in Chapter&#160;28.</p>
			<p class="h4-text ParaOverride-3"><span class="h4-head">Juvenile xanthogranuloma</span> <span class="italic">Juvenile xanthogranuloma</span> is a nonneoplastic histiocytic proliferation that develops in infants younger than 2&#160;years. It is characterized by the presence of Touton &#173;giant cells. Skin involvement—&#173;consisting of one or more small, round, orange or tan papules—is typically but not always pres&#173;ent. Iris lesions are relatively rare and virtually always unilateral. The fleshy, yellow-&#173;brown masses may be small and localized or may diffusely infiltrate the entire iris, resulting in heterochromia. Spontaneous bleeding with hyphema is a characteristic clinical pre&#173;sen&#173;ta&#173;tion. Secondary glaucoma may cause acute pain, photophobia, and vision loss. &#173;Those at greatest risk for ocular involvement are &#173;children with multiple skin lesions.</p>
			<p class="body-text">Juvenile xanthogranuloma is a self-&#173;limited condition that usually regresses spontaneously by age 5&#160;years, but to avoid complications, treatment is indicated for ocular involvement. Topical corticosteroids and pharmacologic agents to lower intraocular pressure, given as necessary, are generally sufficient to control the prob&#173;lem. Surgical excision or radiation should be considered if intractable glaucoma is pres&#173;ent.</p>
			<p class="h4-text ParaOverride-3"><span class="h4-head">Iris mammillations</span> <span class="italic">Iris mammillations</span> may be unilateral or bilateral. They appear as numerous tiny, diffuse, pigmented nodules on the surface of the iris (<span class="xref-figure">Fig 21-19</span>). They are more common in darkly pigmented eyes and are usually the same color as the iris. &#173;These nodules may be bilateral, autosomal dominant, and isolated, or they may be associated with oculodermal melanocytosis or phakomatosis pigmentovascularis type IIb (nevus flammeus with per&#173;sis&#173;tent, aberrant mongolian spots). Iris mammillations have also been reported in cases of ciliary body tumor and choroidal melanoma. They must be differentiated from Lisch nodules; mammillations are usually dark brown, smooth, uniformly distributed, and equal in size or slightly larger near the pupil. The incidence of iris mammillations is higher among patients with neurofibromatosis type 1.</p>
			<p class="h4-text"><span class="h4-head">Brushfield spots</span> Focal areas of iris stromal hyperplasia surrounded by relative hypoplasia occur in up to 90% of patients with Down syndrome; in such patients, &#173;these areas are known as <span class="italic">Brushfield spots.</span> They are hypopigmented. Similar lesions, known as <span class="italic">Wolfflin nodules,</span> occur in up to 24% of healthy individuals. Neither condition is visually significant.</p>
			<p class="h3">Cysts</p>
			<p class="h4-text ParaOverride-13"><span class="h4-head">Primary iris cysts</span> &#173;These cysts may originate from the iris pigment epithelium or the iris stroma.</p>
			<p class="h5-text"><span class="h5-head">cysts of iris pigment epithelium</span> Spontaneous cysts of the iris pigment epithelium result from a separation of the 2 layers of epithelium anywhere between the pupil and ciliary body (<span class="xref-figure">Fig 21-20</span>). &#173;These cysts tend to be stable and rarely cause ocular complications. They are usually not diagnosed &#173;until the teenaged years.</p>
			<p class="h5-text"><span class="h5-head">central cysts</span> Pigment epithelial cysts at the pupillary border, also termed <span class="italic">iris flocculi,</span> are sometimes hereditary. In rare cases, they may be from an <span class="italic">ACTA2</span> mutation (see the section “Congenital mydriasis”). They are usually diagnosed in infancy. The cysts may enlarge slowly but generally remain asymptomatic and rarely require treatment. Cholinesterase-&#173;inhibiting eyedrops such as echothiophate may produce similar pupillary cysts, especially in young phakic eyes. Discontinuation of the drug or concomitant administration of phenylephrine generally results in improvement.</p>
			<p class="h5-text"><span class="h5-head">cysts of iris stroma</span> Primary iris stromal cysts are often diagnosed in infancy. They are most likely caused by sequestration of epithelium during embryologic development. The epithelium-&#173;lined stromal cysts usually contain goblet cells, and they may enlarge, causing obstruction of the visual axis, glaucoma, corneal decompensation, or iritis from cyst leakage.</p>
			<p class="body-text">Numerous treatments have been described, including cyst aspiration and photocoagulation or photodisruption, but the sudden release of cystic contents may result in transient iritis and glaucoma. &#173;Because of &#173;these potential complications and frequent cyst recurrence, surgical excision may be the preferred treatment method. Iris stromal cysts account for approximately 16% of childhood iris cysts. The visual prognosis is guarded.</p>
			<p class="h4-text"><span class="h4-head">Secondary iris cysts</span> Secondary iris cysts have been reported in childhood &#173;after trauma; they are also associated with tumors and iris nevi.</p>
			<p class="h2 ParaOverride-4">Ciliary Body</p>
			<p class="h3-h2">Medulloepithelioma</p>
			<p class="body-text--no-indent-">A <span class="italic">medulloepithelioma (diktyoma)</span> originates from the nonpigmented epithelium of the ciliary body and most often pres&#173;ents as an iris mass during the first de&#173;cade of life. Secondary glaucoma, hyphema, and ectopia lentis et pupillae or sectoral cataract (<span class="xref-figure">Fig 21-21</span>) are less frequent initial manifestations. This rare lesion shows a spectrum of clinical and pathologic characteristics, ranging from benign to malignant. Although distant metastasis is rare, local invasion can lead to death. Teratoid ele&#173;ments are often pres&#173;ent. Enucleation is usually required and is curative in most cases.</p>
			</div>
			<p class="h1">Miscellaneous Clinical Signs</p>
			<div id="Chapt21_Top9">
			<p class="h2-h1">Pediatric Iris Heterochromia</p>
			<p class="body-text--no-indent-">The differential diagnosis of pediatric iris heterochromia is extensive. &#173;Causes can be classified based on &#173;whether the condition is congenital or acquired and &#173;whether the affected eye is hypopigmented or hyperpigmented (<span class="xref-figure">Fig 21-22</span>, <span class="xref-table">&#173;Table&#160;21-3</span>). Trauma, chronic iridocyclitis, intraocular surgery, and use of topical prostaglandin analogues are impor&#173;tant &#173;causes of acquired hyperpigmented heterochromia. &#173;Whether congenital or acquired, hypopigmented heterochromia that is associated with a more miotic pupil and ptosis on the ipsilateral side should prompt a workup for Horner syndrome.</p>
			<p class="h2">Anisocoria</p>
			<p class="body-text--no-indent-">In&#173;equality in the dia&#173;meters of the 2 pupils is called <span class="italic">anisocoria.</span> For a detailed discussion of anisocoria and the following conditions, see BCSC Section&#160;5, <span class="italic">Neuro-&#173;Ophthalmology.</span></p>
			<p class="h3">Physiologic anisocoria</p>
			<p class="body-text--no-indent-">Physiologic anisocoria is a common cause of a difference in size between the 2 pupils. This difference is usually less than 1&#160;mm and can vary from day to day in an individual. The in&#173;equality does not change significantly when the patient is in dim light or bright light.</p>
			<p class="h3">Tonic pupil</p>
			<p class="body-text--no-indent-">Features of a tonic pupil include anisocoria that is greater in bright light and a pupil that is sluggishly and segmentally responsive to light and more responsive to near effort. Greater-&#173;than-&#173;normal constriction in response to dilute pilocarpine is diagnostic. Pos&#173;si&#173;ble etiologic &#173;causes in &#173;children include varicella-&#173;zoster virus infection and Adie syndrome with absence of deep tendon reflexes.</p>
			<p class="h3">Horner syndrome</p>
			<p class="body-text--no-indent-">A lesion at any location along the oculosympathetic pathway may lead to <span class="italic">Horner syndrome.</span> Affected patients have anisocoria that is greater in dim light and ptosis secondary to paralysis of the M<span class="accent">ü</span>ller muscle. Congenital cases may be associated with iris heterochromia in which the affected iris is lighter in color. However, the heterochromia may not be pres&#173;ent in infants &#173;because the normal iris needs time to acquire pigment.</p>
			<p class="body-text">The diagnosis of Horner syndrome can be confirmed with the use of topical cocaine or apraclonidine drops. Apraclonidine reverses the anisocoria, causing dilation of the affected (smaller) pupil and having no effect on the normal pupil. This agent should be used with caution in young &#173;children, as it may cause excessive sedation owing to its central ner&#173;vous system effects. Additional pharmacologic testing may not be necessary in the presence of typical clinical findings.</p>
			<p class="body-text">Horner syndrome in &#173;children may be idiopathic or may be caused by trauma, surgery, or the presence of neuroblastoma affecting the sympathetic chain in the chest. For &#173;children with acquired Horner syndrome but no history of trauma or surgery that could explain the anisocoria, evaluation should include imaging studies of the brain, neck, and chest. The value of mea&#173;sur&#173;ing catecholamine excretion has been questioned &#173;because some patients with normal catecholamine mea&#173;sure&#173;ments have been found to have neuroblastomas.</p>
		</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer003">
				<div id="_idContainer001" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C21_p000-000_1P_v2-web-resources/image/AAX-10020.jpg" alt="" />
				</div>
				<div id="_idContainer002" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 21-1</span> Megalocornea. The depth of the anterior chamber in this male infant was more than 19% of total axial length, a feature that is useful for distinguishing the anomaly from buphthalmos. <span class="figure-source-note">(Courtesy of Arif O. Khan, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer006">
				<div id="_idContainer004" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 21-2</span> Microcornea, right eye.</p>
				</div>
				<div id="_idContainer005" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C21_p000-000_1P_v2-web-resources/image/AAX-2288.jpg" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer009">
				<div id="_idContainer007" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C21_p000-000_1P_v2-web-resources/image/AAX-2289.png" alt="" />
				</div>
				<div id="_idContainer008" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 21-3</span> Posterior embryotoxon <span class="figure-caption-italic">(arrow)</span> in Axenfeld-Rieger syndrome.</p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer012">
				<div id="_idContainer010" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C21_p000-000_1P_v2-web-resources/image/AAX-10021.png" alt="" />
				</div>
				<div id="_idContainer011" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 21-4</span> An extremely flat cornea is apparent in this child with cornea plana. Also note the indistinct limbus and irregular pupil. <span class="figure-source-note">(Reproduced with permission from Khan AO. Ocular genetic disease in the Middle East. </span><span class="figure-source-emphasis">Curr Opin Ophthalmol.</span><span class="figure-source-note"> 2013;24(5):369–378.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer015">
				<div id="_idContainer013" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C21_p000-000_1P_v2-web-resources/image/AAX-10022.png" alt="" />
				</div>
				<div id="_idContainer014" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 21-5</span> <span class="figure-caption-bold">A,</span> Epibulbar limbal dermoid with hair growing in the center. <span class="figure-caption-bold">B,</span> Corneal dermoid. <span class="figure-source-note">(Part A courtesy of Ken K. Nischal, MD; part B courtesy of Robert W. Hered, MD.)</span></p>
				</div>
			</div>
		</div>
		<div id="_idContainer016" class="_idGenObjectStyleOverride-1">
			<table id="table001" class="Basic-Table">
				<colgroup>
					<col class="_idGenTableRowColumn-1" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-3" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-4" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-5" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table _1-BCSC-table-title" colspan="7">
							<p class="table-title"><span class="table-number">&#173;Table&#160;21-1</span> Differential Diagnosis of Infantile Corneal Opacities</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-7">
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1">
							<p class="table-column-head">Entity</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1" />
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1">
							<p class="table-column-head">Location and Description of Opacity</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1" />
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1">
							<p class="table-column-head">Other Signs</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1" />
						<td class="Basic-Table _3-BCSC-table-column-head CellOverride-1">
							<p class="table-column-head">Method of Diagnosis</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table _4-BCSC-table-body-first-row">
							<p class="table-body">Sclerocornea (total corneal opacification)</p>
						</td>
						<td class="Basic-Table _4-BCSC-table-body-first-row" />
						<td class="Basic-Table _4-BCSC-table-body-first-row">
							<p class="table-body">Peripheral opacity, clearest centrally; unilateral or bilateral; often vascularized</p>
						</td>
						<td class="Basic-Table _4-BCSC-table-body-first-row" />
						<td class="Basic-Table _4-BCSC-table-body-first-row">
							<p class="table-body">Flat cornea</p>
						</td>
						<td class="Basic-Table _4-BCSC-table-body-first-row" />
						<td class="Basic-Table _4-BCSC-table-body-first-row">
							<p class="table-body">Inspection; anterior segment imaging</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-9">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Forceps injury</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Central opacity; unilateral</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Breaks in Descemet membrane</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">History</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-10">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Posterior corneal defect</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Central opacity; unilateral or bilateral</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Iris adherence to cornea; posterior keratoconus</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Inspection</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-11">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Infection</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Central or diffuse opacity; unilateral or bilateral</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Dendrites, infiltrate, ulceration</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Culture, polymerase chain reaction, serologic tests</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-9">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Mucopolysaccharidosis</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Diffuse opacity; bilateral</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Smooth epithelium</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Biochemical testing</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-12">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Congenital hereditary stromal dystrophy (CHSD)</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Diffuse opacity; bilateral</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Stromal opacities; normal thickness; normal epithelium</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Examination of &#173;family members for autosomal dominance</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-10">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Congenital hereditary endothelial dystrophy (CHED)</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Diffuse opacity; bilateral</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Thickened cornea</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Inspection</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-11">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Infantile glaucoma</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Diffuse opacity; unilateral or bilateral</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Enlarged cornea; breaks in Descemet membrane</p>
						</td>
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2" />
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-body">Tonometry for elevated intraocular pressure</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-13">
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-2">
							<p class="table-body">Dermoid</p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-2" />
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-2">
							<p class="table-body">Inferotemporal opacity; unilateral; elevated; surface hair; keratinized; usually limbal</p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-2" />
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-2">
							<p class="table-body">Associated with Goldenhar syndrome</p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-2" />
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-2">
							<p class="table-body">Inspection</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div id="_idContainer017" class="_idGenObjectStyleOverride-1">
			<table id="table002" class="Basic-Table">
				<colgroup>
					<col class="_idGenTableRowColumn-14" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table _1-BCSC-table-title">
							<p class="table-title"><span class="table-number">&#173;Table&#160;21-2</span> Primary and Secondary Corneal Opacities: An Alternative Classification</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-15">
						<td class="Basic-Table _4-BCSC-table-body-first-row">
							<p class="table-head">Primary</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-indent-1">Corneal dystrophies (eg, CHED, PPCD, CHSD)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-indent-1">Corneal dermoid</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-17">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3">
							<p class="table-head">Secondary</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-indent-1">Posterior corneal depression</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-indent-1">Kerato-&#173;irido-&#173;lenticular dysgenesis (KILD)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-indent-2">Iridocorneal adhesions only (Peters anomaly type 1)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-indent-2">Failure of lens to separate from cornea (Peters anomaly type 2)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-indent-2">Lens separation but failure to form thereafter (sclerocornea)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-indent-2">Failure of lens to form (sclerocornea)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-indent-1">Congenital or infantile glaucoma</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-indent-1">Traumatic breaks in Descemet membrane</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-indent-1">Infection</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-18">
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-2">
							<p class="table-indent-1">Metabolic &#173;causes</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-19">
						<td class="Basic-Table _8-BCSC-table-note">
							<p class="table-source-note">CHED <span class="symbol">=</span> congenital hereditary endothelial dystrophy; CHSD <span class="symbol">=</span> congenital hereditary stromal dystrophy; PPCD <span class="symbol">=</span> posterior polymorphous corneal dystrophy.</p>
							<p class="table-source-note">Adapted with permission from Nischal KK. A new approach to the classification of neonatal corneal opacities. <span class="table-source-emphasis">Curr Opin Ophthalmol.</span> 2012;23(5):344–354.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer020">
				<div id="_idContainer018" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C21_p000-000_1P_v2-web-resources/image/AAX-10024.png" alt="" />
				</div>
				<div id="_idContainer019" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 21-6</span> Congenital hereditary endothelial dystrophy. Note the diffuse mosaic haze, bluish discoloration, and thickness of the cornea. <span class="figure-source-note">(Courtesy of Arif O. Khan, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer021" class="_idGenObjectStyleOverride-1">
				<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C21_p000-000_1P_v2-web-resources/image/AAX-10025.png" alt="" />
			</div>
		</div>
		<div id="_idContainer022" class="Basic-Text-Frame">
			<p class="figure-caption"><span class="figure-number">Figure 21-7</span> <span class="figure-caption-bold">A,</span> Corneal opacity secondary to iridocorneal adhesion (Peters anomaly type 1). <span class="figure-caption-bold">B,</span>&#160;Corneal opacity secondary to keratolenticular adhesion (Peters anomaly type 2). <span class="figure-caption-bold">C,</span> A Peters phenotype of central lens opacity with keratolenticular adhesion. <span class="figure-caption-bold">D,</span> Bilateral posterior corneal defect with a thin posterior membrane, causing the appearance of a central cyst in an opacified cornea. <span class="figure-source-note">(Parts A and B courtesy of Ken K. Nischal, MD; parts C and D courtesy of Arif O. Khan, MD.)</span></p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer025">
				<div id="_idContainer023" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C21_p000-000_1P_v2-web-resources/image/AAX-10028.png" alt="" />
				</div>
				<div id="_idContainer024" class="Basic-Text-Frame">
					<p class="figure-caption ParaOverride-16"><span class="figure-number">Figure 21-8</span> Bilateral sclerocornea. <span class="figure-source-note">(Courtesy of Arif O. Khan, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer028">
				<div id="_idContainer026" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C21_p000-000_1P_v2-web-resources/image/AAX-10029.png" alt="" />
				</div>
				<div id="_idContainer027" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 21-9</span> Primary congenital glaucoma. <span class="figure-source-note">(Reproduced with permission from Khan AO. Genetics of primary glaucoma. </span><span class="figure-source-emphasis">Curr Opin Ophthalmol.</span><span class="figure-source-note"> 2011;22(5):347–355.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer031">
				<div id="_idContainer029" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C21_p000-000_1P_v2-web-resources/image/AAX-10030.png" alt="" />
				</div>
				<div id="_idContainer030" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 21-10</span> Haab striae in an eye that underwent peripheral iridectomy related to prior glaucoma surgery. <span class="figure-source-note">(Courtesy of Arif O. Khan, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer034">
				<div id="_idContainer032" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C21_p000-000_1P_v2-web-resources/image/AAX-10031.png" alt="" />
				</div>
				<div id="_idContainer033" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 21-11</span> Descemet tears from minor trauma in a child with brittle cornea syndrome. <span class="figure-source-note">(Cou</span><span class="figure-source-note">r</span><span class="figure-source-note">-<br />tesy of Arif O. Khan, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer037">
				<div id="_idContainer035" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 21-12</span> Persistent pupillary membrane. Uncorrected visual acuity was 20/40.</p>
				</div>
				<div id="_idContainer036" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C21_p000-000_1P_v2-web-resources/image/AAX-2306.jpg" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer040">
				<div id="_idContainer038" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 21-13</span> Gonioscopic view in Axenfeld-Rieger syndrome.</p>
				</div>
				<div id="_idContainer039" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C21_p000-000_1P_v2-web-resources/image/AAX-2290.jpg" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer043">
				<div id="_idContainer041" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C21_p000-000_1P_v2-web-resources/image/AAX-2291.png" alt="" />
				</div>
				<div id="_idContainer042" class="Basic-Text-Frame">
					<p class="figure-caption ParaOverride-16"><span class="figure-number">Figure 21-14</span> Axenfeld-Rieger syndrome, bilateral.</p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer046">
				<div id="_idContainer044" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C21_p000-000_1P_v2-web-resources/image/AAX-2292.jpg" alt="" />
				</div>
				<div id="_idContainer045" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 21-15</span> Axenfeld-Rieger syndrome. Note variation compared with Figures 21-13 and 21-14. <span class="figure-source-note">(Courtesy of Jane D. Kivlin, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer049">
				<div id="_idContainer047" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 21-16</span> Typical iris coloboma, right eye.</p>
				</div>
				<div id="_idContainer048" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C21_p000-000_1P_v2-web-resources/image/AAX-2302.jpg" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer052">
				<div id="_idContainer050" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 21-17</span> Aniridia in an infant. Both the ciliary processes and the edge of the lens are visible. Also present are persistent pupillary membrane fibers and a small central anterior polar cataract.</p>
				</div>
				<div id="_idContainer051" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C21_p000-000_1P_v2-web-resources/image/AAX-2301.jpg" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer055">
				<div id="_idContainer053" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 21-18</span> Pseudopolycoria secondary to Axenfeld-Rieger syndrome. <span class="figure-source-note">(Courtesy of John W. Simon, MD.)</span></p>
				</div>
				<div id="_idContainer054" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C21_p000-000_1P_v2-web-resources/image/AAX-2307.jpg" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer058">
				<div id="_idContainer056" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 21-20</span> Cysts of the iris pigment epithelium at the pupillary border (flocculi).</p>
				</div>
				<div id="_idContainer057" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C21_p000-000_1P_v2-web-resources/image/AAX-2304.jpg" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer061">
				<div id="_idContainer059" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 21-19</span> Iris mammillations. The nodules are diffuse and are the same color as the iris (Lisch nodules, by contrast, are lighter or darker than the surrounding iris). <span class="figure-source-note">(Courtesy of </span><span class="figure-source-note">A</span><span class="figure-source-note">r</span><span class="figure-source-note">lene Drack, MD.)</span></p>
				</div>
				<div id="_idContainer060" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C21_p000-000_1P_v2-web-resources/image/AAX-3538.jpg" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer064">
				<div id="_idContainer062" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C21_p000-000_1P_v2-web-resources/image/AAX-8008.png" alt="" />
				</div>
				<div id="_idContainer063" class="Basic-Text-Frame">
					<p class="figure-caption ParaOverride-16"><span class="figure-number">Figure 21-21</span> Sectoral cataract adjacent to medulloepithelioma. <span class="figure-source-note">(Courtesy of Ken K. Nischal, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer067">
				<div id="_idContainer065" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 21-22</span> Iris heterochromia. The left iris has become darker since development of a traumatic cataract. <span class="figure-source-note">(Courtesy of John W. Simon, MD.)</span></p>
				</div>
				<div id="_idContainer066" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC1819_S06_C21_p000-000_1P_v2-web-resources/image/AAX-2305.jpg" alt="" />
				</div>
			</div>
		</div>
		<div id="_idContainer068" class="_idGenObjectStyleOverride-1">
			<table id="table003" class="Basic-Table">
				<colgroup>
					<col class="_idGenTableRowColumn-14" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table _1-BCSC-table-title">
							<p class="table-title"><span class="table-number">&#173;Table&#160;21-3</span> &#173;Causes of Pediatric Iris Heterochromia</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-15">
						<td class="Basic-Table _4-BCSC-table-body-first-row">
							<p class="table-head">Hypochromic heterochromia</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-indent-1">Horner syndrome (congenital or early in life)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-indent-1">Incontinentia pigmenti (Bloch-&#173;Sulzberger syndrome; rare)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-indent-1">Fuchs heterochromia</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-indent-1">Waardenburg syndrome</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-indent-1">Nonpigmented tumors</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-indent-1">Hypomelanosis of Ito</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-20">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-4">
							<p class="table-head">Hyperchromic heterochromia</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-17">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-3">
							<p class="table-indent-1">Oculodermal melanocytosis (associated with glaucoma in nonwhite adults)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-indent-1">Pigmented tumors</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-indent-1">Siderosis</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-indent-1">Iris ectropion syndrome</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-indent-1">Extensive rubeosis</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-indent-1">Port-&#173;wine stain</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-indent-1">Trauma</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-indent-1">Chronic iridocyclitis</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table _5-BCSC-table-body CellOverride-2">
							<p class="table-indent-1">Intraocular surgery</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-18">
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-2">
							<p class="table-indent-1">Topical prostaglandin analogues</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-21">
						<td class="Basic-Table _8-BCSC-table-note">
							<p class="table-source-note">Modified with permission from Roy FH. <span class="table-source-emphasis">Ocular Differential Diagnosis.</span> 3rd&#160;ed. Philadelphia: Lea <br />&amp; Febiger; 1984.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
	</body>
</html>
